ReviewTranslational lung cancer research2021

Emerging biomarkers for neoadjuvant immune checkpoint inhibitors in operable non-small cell lung cancer.

Monika Pradhan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.